Hepatitis B vaccination and hepatocellular carcinoma in Taiwan

Pediatrics

Volumn 99, Issue 3, 1997, Pages 351-353

  Lee, Cheng Liang ^a,b   Ko, Ying Chin ^b  

^a Kaohsiung Municipal Min Sheng Hospital   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PREVENTION; CHILD; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; INFANT; LIVER CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TAIWAN; VACCINATION;

CARCINOMA, HEPATOCELLULAR; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; INCIDENCE; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; REGRESSION ANALYSIS; TAIWAN;

EID: 0030962473     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.99.3.351     Document Type: Article

References (18)

1. Blumberg BS, London WT. Hepatitis B virus and the prevention of primary hepatocellular carcinoma. N Engl J Med. 1981;304:782-784
2. Beasley RP, Hwang LY, Lin CC, Chice CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet. 1981;2:1129-1133
3. Srivatanakul P, Parkin DM, Khlat M, et al. Liver cancer in Thailand: II. A case-control study of hepatocellular carcinoma. Int J Cancer. 1991;48: 329-332
4. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med. 1981;305: 1067-1073
5. Chen DS, Sung JL. Hepatitis B virus infection and chronic liver diseases in Taiwan. Acta Hepatogastroenterol. 1978;25:423-430
6. Stevens CE, Beasley RP, Tsui JJ, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292:771-774
7. Chen DS, Hsu NHM, Sung JL, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA. 1987;257:2597-2603
8. Hall AJ, Inskip HM, Loik F, et al. The Gambia hepatitis intervention study. Cancer Res. 1987;47:5782-5787
9. Centers for Disease Control, Immunization Practices Advisory Committee. Postexposure prophylaxis of hepatitis B. MMWR. 1984;33: 285-290
10. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2:1099-1102
11. Hall AJ, Inskip HM, Loik F, et al. Hepatitis B vaccine in the expanded progrmme of immunisation: the Gambian experience. Lancet. 1989;1: 1057-1060
12. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M. E antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976;294:746-749
13. Delaplane D, Yogev R, Crussi F, Shulman ST. Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics. 1983;72:176-180
14. National Health Department of Taiwan. Health Statistics: Vital Statistics of Republic of China. Taipei, Taiwan: Department of Health; 1974-1993
15. Simonetti RG, Camma C, Fiorello F, Politi F, D'amico G, Pagliaro L. Hepatocellular carcinoma: a worldwide problem and the major risk factor. Dig Dis Sci. 1991;36:962-972
16. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol. 1986;18:301-307
17. Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol. 1991;34:96-99
18. Hsu HM, Chen DS, Chuang CH, et al. Efficacy of a mass hepatitis B vaccination program in Taiwan. JAMA. 1988;260:2231-2235